Influence oft prebiotics and probiotics on gut colonization, weight, lipid profile and blood sugar levels in overweight adults

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00008729

Enrollment

Registered

2015-06-29

Start date

2015-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.90 E11.90

Interventions

Group 1: Placebo (identical capsules containing silica) for twelve weeks Group 2: UK Darmflora, (PZN-00477512) Inulin, Lactobacillus acidophilus, Lactobazillus rhamnosus, Lactobazillus casei, Bifido

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: participants: pre-obese (BMI 25 - 29,9) and obese (BMI = 30)

Exclusion criteria

Exclusion criteria: Immunosuppression, inflammatory bowel diseases, pregnancy, therapy with antibiotics

Design outcomes

Primary

Measure	Time frame
weight loss after 4, 8 and 12 weeks	—

Secondary

Measure	Time frame
blood sugar reduction after 4, 8 and 12 weeks	—

Countries

Germany

Contacts

Public ContactMichaela Axt-Gadermann

Hochschule Coburg

michaela.axt-gadermann@hs-coburg.de0661-605860

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026